Emily Atkinson is a Maplethorpe Research Fellow at UCL School of Pharmacy, focusing on growth factor-based therapies for nervous system damage. Her research interests include cell therapies, growth factor mimetics, computational peptide-receptor docking and the use of molecular dynamics to model protein-protein interactions. She completed her PhD in peptide growth factor mimetics and therapeutic cell delivery for the treatment of central nervous system damage and disease at UCL in 2024, under the supervision of Dr. Rachael Dickman, Prof. James Phillips and Prof. Alethea Tabor. Prior to this, she completed her MChem in Medicinal Chemistry at Newcastle University, with a year of industrial training at CPI where she worked on pharmaceutical formulation.